Clinical Trial About Acute Lymphocytic Leukemia

Executive Summary

Clinical trials are considered a better method for treating acute lymphocytic leukemia. The evaluation of new drugs, different combinations of treatments, new approaches to surgery, and new therapies are a part of clinical trials of acute lymphocytic leukemia. Volunteers or patients willing to participate in the clinical trials should communicate with their doctor and healthcare team and research expertise to make well-decided informed choices regarding participation while signing informed consent. Clinical trials also focus on deriving methods to manage and relieve the side effects of cancer treatments. The volunteers willingly participate since they know the studies are a way to help advance the treatment of acute lymphocytic leukemia. Eligibility criteria for acute lymphocytic leukemia clinical trials ensure that the participants are safe, bound to no ill effects, and well-structured research.

Clinical Trials for Acute Lymphocytic Leukemia

On the path to finding different ways to treat cancer, various research and trials are underway to find safe and effective treatments other than the standard ones. Every drug that is used now was once tested in clinical trials. The clinical studies mainly focus on finding a safe, effective, and better treatment or diagnostic procedure. They evaluate new chemotherapy or radiotherapy drugs for better treatment of cancer ​1​.

Taking part in clinical trials can benefit people by receiving treatment before it is available. As the coin has two sides, there are some risks with the clinical trials, such as the side effects and the possibility of new clinical trials not working. Clinical trials of drugs and other therapies can relieve the symptoms and side effects of treatments like chemotherapy, radiotherapy, etc. And so, it is strongly encouraged to talk with their health care team about the pros and cons of joining a specific study.

Participating in clinical trials can have many reasons. For some people, taking part in a clinical trial is the only option to receive the best treatment for the type of cancer. Because standard treatments are not perfect, people are willing to face the uncertainty and challenges of a clinical trial to seek a better result. Some clinical trials study new ways to relieve symptoms and side effects during treatment ​2​. Others learn ways to manage the late effects that may happen a long time after treatment. 

Cost of Treatment and Eligibility

Insurance and the costs of clinical trials change depending upon location and study. Some of the expenses from participating in the clinical trial are reimbursed in several programs. Clinical trials also have specific “eligibility criteria” rules that help research patients be safe. You and your research team carefully review these criteria together. Hence, people participating in a clinical trial can stop participating at any time for any medical or personal reasons. The reasons may include that the new treatment is not working or has severe side effects. Experts keep an eye on clinical trials for any problems with each study.


  1. 1.
    Larson RA. RECENT CLINICAL TRIALS IN ACUTE LYMPHOCYTIC LEUKEMIA BY THE CANCER AND LEUKEMIA GROUP B. Hematology/Oncology Clinics of North America. Published online December 2000:1367-1379. doi:10.1016/s0889-8588(05)70191-x
  2. 2.
    Gökbuget N, Dombret H, Bassan R, Wadleigh M, Doubek M, Ribera J. Inclusion and response criteria for clinical trials in relapsed/refractory acute lymphoblastic leukemia and usefulness of historical control trials. Haematologica. Published online March 2017:e118-e119. doi:10.3324/haematol.2017.163816